Exploring iDose® TR: The Future of Glaucoma Management thumbnail

Exploring iDose® TR: The Future of Glaucoma Management

Published Nov 15, 24
1 min read


iDose® TR is a game-changing innovation in the treatment of glaucoma, offering a long-term and efficient method for managing intraocular pressure (IOP). In contrast to traditional eye drops that demand frequent use, iDose® TR is a tiny, implantable device crafted to provide a controlled medication delivery directly into the eye over an extended period. This cutting-edge approach reduces the burden of constant dosing, significantly improving patient adherence and overall treatment results.

At Eye Center South, we are honored to introduce iDose® TR as part of our comprehensive glaucoma care. The device is implanted during a simple and low-risk procedure, designed with your ease in mind. Once in place, it provides a steady dose of the prescribed medication, keeping IOP levels consistent and ensuring your visual health. Patients who have difficulty managing the challenges of daily eye drop regimens can benefit greatly from this cutting-edge treatment.



Visit for more info At Eye Center South